Spectrum Pharmaceuticals is a biopharmaceutical company that develops and sells oncology and hematology drugs. Their products include Eflapegrastim, Poziotinib, and Anti-CD20-IFNa. They have agreements with Hanmi Pharmaceutical, The University of Texas M.D. Anderson Cancer Center, and ImmunGene, Inc. The company was founded in 1987 and is based in Boston, Massachusetts.